← Open Payments lookup

MELISA STEELE: Open Payments

NPI 1003923988 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,113 in 90 payments from 13 companies in 2025. Trend: 2023 $1,307 · 2024 $1,282 · 2025 $2,113

Food & beverage: $2,071Education: $42
CompanyPaymentsAmount
GENZYME CORPORATION24$441
AstraZeneca Pharmaceuticals LP15$430
Novartis Pharmaceuticals Corporation16$270
GlaxoSmithKline, LLC.11$241
Regeneron Healthcare Solutions, Inc.8$139
Organon LLC1$125
Grifols USA, LLC4$119
ARS Pharmaceuticals Operations, Inc.4$97
Regeneron Pharmaceuticals, Inc.1$84
Takeda Pharmaceuticals U.S.A., Inc.2$59

Products named: DUPIXENT, NUCALA, AIRSUPRA, VTAMA, FASENRA, Prolastin-C Liquid, TEZSPIRE, Rhapsido.

Industry payments across UT — which companies pay providers there.